Proactive Investors - Run By Investors For Investors

Chemistree Technology adds cannabis exec Nicholas Zitelli to board

Zitelli is now the part-owner and chief cannabis officer of Trans High Corporation, the parent company of the 45-year-old High Times magazine
medicinal cannabis and Rx sheet
Chemistree is an investment company focused on acquiring and developing cannabis assets in the US and Canada

Chemistree Technology Inc (CSE:CHM) (OTCMKTS:CHMJF) announced Tuesday that it has succeeded in recruiting a seasoned cannabis industry executive Nicholas Zitelli to its board of directors.

Zitelli is now the part-owner, director and chief cannabis officer of Trans High Corporation, the parent company of the 45-year-old High Times magazine. He’s also the founder and CEO of the Cannabis Genetics Institute, a research and development institute focused on the breeding of medicinal cannabis, set up in Amsterdam in 2014.

READ: Chemistree Technology ‘confident’ of being granted Desert Hot Springs permit for its new cannabis facility

Most recently, he was also named CEO of the newly-formed group Applied Cannabis Sciences LLC, which aims to acquire and operate medical marijuana licenses in the Eastern US and boasts projects in New Jersey, New York and Massachusetts. And he's also written hundreds of articles covering a range of topics in cannabis science under the pen name Nico Escondido.

“These are exciting times for the company and Mr. Zitelli will be a truly outstanding addition to our board of directors,” said Karl Kottmeier, in a statement. “His worldwide network through the professional cannabis community, in addition to his excellent reputation, will unquestionably be invaluable assets to our company’s continued growth.”

For his part, Zitelli says he is looking forward to joining Chemistree as it widens its reach.

“I appreciate the opportunity to support Chemistree through the Company's planned expansion, particularly in the US market, and help it to define the future of the cannabis industry,” he said in a statement.

Headquartered in Vancouver, Chemistree is an investment company focused on acquiring and developing cannabis assets in the US and Canada.

Chemistree shares slipped C$0.01 to trade at C$0.60 on Monday.

Contact Ellen Kelleher at [email protected]

-- This story is updated to reflect latest share price movement -- 

 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

data graphic
March 22 2019
The Toronto company is busy meeting what it says is significant demand by building a data asset covering the medical cannabis sector
Empower clinic locations
March 26 2019
Empower Clinics is one of the largest operators of medical-cannabis-focused healthcare in the US
A visual representation of a drug candidate working in a dog
January 28 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use